This document provides a summary of financial performance and stock price analysis for an algorithm company over several periods from 2017-2021. It includes tables with metrics like sales, operating profit, net income, debt ratios, and stock prices. A section analyzes the company's stock price rise probability and compares it to sector averages. It suggests a prospective purchase amount based on the current stock price being very low compared to the indication price range.

1. Performance Analysis of Algorithm (Separate) 206650 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2020.03 2020.06 2020.09 2020.12 2021.03 2021.06
IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep)
Sales 116 249 331 232 63 59 33 130 234 422 71
O-profit -43 53 98 36 5 -32 -46 13 -16 -49 -15
N-income -47 38 -9 -6 68 -115 -620 65 -65 -194 -151
O-rate -37.1 21.3 29.6 4.6 7.9 -54.2 -139.4 10.0 -6.6 -11.7 -32.3
N-rate -40.5 15.3 -2.7 -9.3 107.9 -194.9 -1,878.8 50.0 -27.8 -46.1 -331.6
ROE -25.8 14.9 -2.6 -4.5 65.1 -23.8 -936.4 -217.1 -223.8 -223.5 -259.9
Debt-ratio 47.8 167.5 165.1 126.8 134.2 151.2 1,175.9 61.0 16.7 4.6 257.3
Quick-ratio 186.0 97.5 31.3 104.9 43.7 67.5 33.4 171.0 313.6 596.5 204.3
reserve-ratio 44.3 98.4 158.2 100.3 209.0 189.9 -42.8 453.4 530.9 587.0 321.2
EPS -134 108 -26 -17 194 -328 -1,767 185 -186 -554 -429
BPS 519 727 998 748 1,192 1,163 248 2,762 11,323 46,415 1,341
Dividends 0 0 0 0
2021-05-25
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -95 %
High mid ~ -96 %
Mid ~ -97 %
Low mid ~ -97 %
Low price ~ -98 %
Normal
773 W 773 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Biotechnology 79 72 3,125 1,986
1,763 W 1,763 W 1,433 W
1,433 W 1,433 W 1,103 W Evaluation
2,093 W 2,093 W~ 1,763 W
43,650 W
42.9
1,103 W 1,103 W 773 W
High price
Indication price Range Current stock price Company score
773원 1,103원 1,433원 1,763원 2,093원
High price 43,650원
-98%
-97%
-97%
-96%
-95%
-99%
-98%
-98%
-97%
-97%
-96%
-96%
-95%
-95%
-94%
-94%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
35,000W
40,000W
45,000W
50,000W
Low price Low mid Mid High mid High price
Indication price chart (Separate)
Indication price
eubiologics
Gap
eubiologics

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 206650 Date
Period
Gap
(Indication /
stock)
Color
low price 773 W 773 W ~ 0 W -98 % 621,061 W 803
Low mid 1,103 W 1,103 W ~ 773 W -97 % 616,280 W 559
Mid 1,433 W 1,433 W ~ 1,103 W -97 % 611,499 W 427
High mid 1,763 W 1,763 W ~ 1,433 W -96 % 606,718 W 344
Suggested Purchase
Amount 632,260 W
Number of stocks
purchased 14
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 2,093 W 2,093 W~ ~ 1,763 W -95 % 601,937 W 288
2021-05-25
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
43,650 W High price 45.5 Normal 2,500,000 W
Stock price rise
probability score
A Sector 53.2 50.1 42.3 51.6 45.0 51.4
45.5
B Sector 15.8 45.4 51.6 51.6 29.6 27.9
Total average 34.5 47.8 34.1 21.7 37.3 39.7
2020.12.23 2021.01.25 2021.02.24 2021.03.25 2021.04.22 2021.05.24
2021.02.24 2021.03.25 2021.04.22 2021.05.24
Total of
increase rate
Total score
A Sector -6 % -18 % 18 % -15 % 12 %
-4 % 45.7
B Sector 65 % -76 % 50 % -74 % -6 %
Total average 28 % -40 % -57 % 42 % 6 %
2021.01.25
-6%
-18%
18%
-15%
12%
65%
-76%
50%
-74%
-6%
28%
-40%
-57%
42%
6%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
2021.01.25 2021.02.24 2021.03.25 2021.04.22 2021.05.24
Increase rate of stock price rise
A sector
B sector
Total average
eubiologics
53
50
42
52
45
51
16
45
26
52
30 28
34
48
34
22
37 40
0
10
20
30
40
50
60
2020.12.23 2021.01.25 2021.02.24 2021.03.25 2021.04.22 2021.05.24
Stock price rise probability score
A sector
B sector
Total average

3. may
ded by
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374